Remdesivir can cause infusion reactions, diarrhea, anemia, hyperglycemia, and elevated alanine aminotransferase (ALT)/serum glutamate pyruvate transaminase (SGPT) and aspartate aminotransferase (AST) levels on long-term treatment. The gene discussed is GPT; the disease is anemia.